Cell Therapy Biomanufacturing: Global Markets

February 2021 | 112 pages | ID: C4CCB8F7946AEN
BCC Research

Abstracts

Report Scope:

This research report presents an in-depth analysis of the global cell therapy biomanufacturing market by product type, application and region. The report discusses the key inhibitors to the growth of cell therapy biomanufacturing. The report discusses the role of participants in the supply chain from manufacturers to researchers. The report analyzes key companies operating in the global cell therapy biomanufacturing market. In-depth patent analysis in the report will provide a look at the existing and coming technological trends.

In this report, the cell therapy biomanufacturing market is segmented by product type, application and region. Based on product type, the market is segmented into source of cells (T-cells, Dendritic cells, tumor cells and stem cells), and type of therapy (autologous cell therapies, allogeneic cell therapies). The market by application is categorized into cardiovascular diseases, bone repair, neurological disorders, skeletal muscle repair, cancer and others. The market by region is segmented into North America, Europe, Asia-Pacific and ROW.

Report Includes:

• 23 tables
• An overview of the global markets for cell therapy biomanufacturing
• Estimation of the market size and analyses of global market trends with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2025
• Assessment of market dynamics such as drivers, restraints, opportunities, and identification of growth inhibiting areas that affect the global market
• Detailed description of allogeneic (third party donor cells) and autologous (one's own body cells) forms of cell therapy and analysis of its advantages and limitations
• Information on clinical trials of cell therapies; insights into regulatory scenarios and initiatives by government organization
• Evaluation of current market trends, market size, market forecast, and technological advancements within the industry
• Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies; and a relevant patent analysis
• Company profiles of major players of the industry, including Bristol-Myers Squibb Co., Caladrius Biosciences Inc., Lonza Group Ltd., Merck KGaA and Novartis AG

Contents

CHAPTER 1 INTRODUCTION

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Market Estimates
Information Sources
Primary Research
Secondary Research
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports

CHAPTER 2 SUMMARY AND HIGHLIGHTS

Introduction

CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND

Introduction to Cell Therapy Biomanufacturing
What is Cell Therapy?
Stem Cell Transplantation
Autologous
Allogeneic
Syngeneic
Stem Cell Biomanufacturing and Classification
Based on Ability to Differentiate
Based on Source
Classification of Cell-Based Therapy Technology
Somatic Cell Technologies
Three-Dimensional Technologies
Cell Immortalization Technologies
Genome Editing Technologies
Cell Plasticity Technologies
Ex vivo Gene Modification of Cells Using Viral Vector Technologies
In vivo Gene Modification of Cells Using Viral Vector Technologies
Stem Cell Applications
Mechanism of Cell Therapy
Delivery Method of Cell-Based Therapy
Manufacturing Cell Therapy Models
Role of Contract Manufacturers
Ongoing Clinical Trials
Clinical Trial Network Focused on Stem Cell Treatments

CHAPTER 4 MARKET TRENDS AND CHALLENGES

Challenges
Drivers
Restraints
Opportunity

CHAPTER 5 MARKET BREAKDOWN BY PRODUCT TYPE

Type of Therapy
Source of Cells
Rise in the Demand for Chimeric Antigen Receptor (CAR) T Cell Therapy

CHAPTER 6 MARKET BREAKDOWN BY APPLICATION

Cardiovascular Disease
Microparticles Cell Imitation
Bone Repair
Neurological Disorders
Spinal Cord Injury
Stroke
Parkinson’s Disease
Amyotrophic Lateral Sclerosis
Multiple Sclerosis
Cerebral Palsy
Alzheimer's Disease
Vision Restoration
Vertebral Repair
Batten's Disease
Skeletal Muscle Repair
Intrinsic Healing Mechanisms
Cell Therapy Mechanism
Cancer
Other Diseases

CHAPTER 7 MARKET BREAKDOWN BY REGION

Market Overview
North America
U.S.
Canada
Mexico
Europe
Cardiovascular Diseases in Europe
Contributing Factors for Cardiovascular Diseases (CVD)
Germany
U.K.
France
Asia-Pacific
China
India
Japan
Rest of APAC
Rest of the World
South America
Middle East and Africa

CHAPTER 8 REGULATORY STRUCTURE

FDA Approvals
Cell Therapy for CBER Regulations
Federal Regulation codes
Collection of Cells
Code of Regulation
Legislation Governing Use of Stem Cell Treatments
EU Determination of Regulatory Status
Regulatory Scenario in India

CHAPTER 9 COMPANY PROFILES

BONE THERAPEUTICS SA
BRISTOL-MYERS SQUIBB CO.
CALADRIUS BIOSCIENCES INC.
CELL THERAPIES PTY LTD.
CELLULAR BIOMEDICINE GROUP INC.
IOVANCE BIOTHERAPEUTICS INC.
LONZA GROUP LTD.
MERCK KGAA
NEUROGENERATION INC.
NOVARTIS AG
REGEN BIOPHARMA INC.
REGENEUS LTD.

CHAPTER 10 APPENDIX: REFERENCES

Sources

List Of Tables

LIST OF TABLES

Summary Table: Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2025
Table 1: Types of Stem Cells
Table 2: Global Market for Cell Therapy Biomanufacturing, by Type of Therapy, Through 2025
Table 3: Global Market for Cell Therapy Biomanufacturing, by Source of Cells, Through 2025
Table 4: Global Market for Cell Therapy Biomanufacturing, by Application, Through 2025
Table 5: Treatments for Cardiovascular Diseases
Table 6: Global Market for Cell Therapy Biomanufacturing for Cardiovascular Disease Applications, Through 2025
Table 7: Global Market for Cell Therapy Biomanufacturing for Bone Repair Applications, Through 2025
Table 8: Global Market for Cell Therapy Biomanufacturing for Neurological Disorder Applications, Through 2025
Table 9: Global Market for Cell Therapy Biomanufacturing for Skeletal Muscle Repair Applications, Through 2025
Table 10: Global Market for Cell Therapy Biomanufacturing for Cancer Treatment Applications, Through 2025
Table 11: Global Market for Cell Therapy Biomanufacturing for Other Applications, Through 2025
Table 12: North American Market for Cell Therapy Biomanufacturing, by Country, Through 2025
Table 13: European Market for Cell Therapy Biomanufacturing, by Country, Through 2025
Table 14: Asia-Pacific Market for Cell Therapy Biomanufacturing, by Country, Through 2025
Table 15: Stem Cell Treatment Provided in Australia
Table 16: Bone Therapeutics: Products
Table 17: Bristol-Myers Squibb: Net Revenue, 2017-2019
Table 18: Caladrius Biosciences: Products
Table 19: Iovance Biotherapeutics: Products
Table 20: Merck KGaA: Products
Table 21: Regen BioPharma: Products
Table 22: Regeneus: Products

List Of Figures

LIST OF FIGURES

Summary Figure: Global Market for Cell Therapy Biomanufacturing, by Product Type, 2019-2025
Figure 1: Combination of Stem Cells and Biomaterials
Figure 2: Global Market for Cell Therapy Biomanufacturing Market, by Product Type, 2019-2025
Figure 3: Autologous and Allogeneic Cell Therapy Based on Source
Figure 4: Mechanism of Bone Marrow
Figure 5: Global Market for Cell Therapy Biomanufacturing, by Region, 2019-2025
Figure 6: Global Market Share for Cell Therapy Biomanufacturing, by Region, 2025
Figure 7: North American Market for Cell Therapy Biomanufacturing, 2019-2025
Figure 8: North American Market Share for Cell Therapy Biomanufacturing, by Country, 2019
Figure 9: European Market for Cell Therapy Biomanufacturing, 2019-2025
Figure 10: European Market Share for Cell Therapy Biomanufacturing, by Country, 2019
Figure 11: Asia-Pacific Market for Cell Therapy Biomanufacturing, 2019-2025
Figure 12: Asia-Pacific Market Share for Cell Therapy Biomanufacturing, by Country, 2019
Figure 13: South American Market for Cell Therapy Biomanufacturing, 2019-2025
Figure 14: Middle Eastern and African Market for Cell Therapy Biomanufacturing, 2019-2025